Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Sarcopenia | Research

Single-pool model urea clearance index is associated with sarcopenia and nutritional status in patients undergoing maintenance hemodialysis: a cross-sectional study

Authors: Yan Li, Tingting Xing, Rong Xu, Yan Liu, Xiaoshi Zhong, Yun Liu, Rongshao Tan

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

The single-pool model urea clearance index (single-pool Kt/Vurea; spKt/V) is the most commonly used method for dialysis adequacy assessment. However, only a few studies have examined the relationship between spKt/V values and parameters related to sarcopenia and nutritional status. This study aimed to evaluate whether the spKt/V is an indicator of sarcopenia and nutritional status in patients undergoing maintenance hemodialysis (MHD).

Methods

A total of 142 patients were included in this single-center, cross-sectional study. Venous blood samples were collected shortly before the hemodialysis session. The adequacy of dialysis in patients receiving MHD was assessed using spKt/V. Sarcopenia was identified according to the Asian Working Group for Sarcopenia (2019) definition. Receiver operating characteristic curve and area under the curve were used to evaluate the predictive value of spKt/V in sarcopenia. Univariate and multivariate binary logistic regression analyses were used to determine the association between spKt/V and sarcopenia and nutritional status.

Results

The mean spKt/V level was 1.3 ± 0.2, the prevalence of sarcopenia was 15.5% in patients on MHD. The best cutoff value of spKt/V in sarcopenia was 1.45 for both sexes, 1.33 and 1.45 for men and women, respectively (P < 0.05). The multivariate binary logistic regression shown that the spKt/V was independently positively associated with sarcopenia (OR = 122.88, 95% CI = 0.64–0.87, P = 0.002). Grouping spKt/V by the best cutoff value, when spKt/V ≥ 1.45, the OR of sarcopenia was 11.75 (95% CI = 3.16–43.67, P < 0.001). Subgroup analyses showed that when spKt/V ≥ 1.33 in men and spKt/V ≥ 1.45 in woman, the OR of sarcopenia was 9.73 (95% CI = 2.25–42.11, P = 0.002) and 14.52 (95% CI = 1.06–199.67, P = 0.045), respectively.

Conclusions

The present study showed that spKt/V was an important influencing factor of sarcopenia and malnutrition in Asian patients on MHD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang XH, Mitch WE, Price SR. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. NAT REV NEPHROL. 2022;18(3):138–52.CrossRefPubMed Wang XH, Mitch WE, Price SR. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. NAT REV NEPHROL. 2022;18(3):138–52.CrossRefPubMed
2.
go back to reference Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K. Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015;18(3):254–62.CrossRefPubMedPubMedCentral Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K. Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015;18(3):254–62.CrossRefPubMedPubMedCentral
3.
go back to reference Koppe L, Fouque D, Kalantar-Zadeh K. Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers. J Cachexia Sarcopenia Muscle. 2019;10(3):479–84.CrossRefPubMedPubMedCentral Koppe L, Fouque D, Kalantar-Zadeh K. Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers. J Cachexia Sarcopenia Muscle. 2019;10(3):479–84.CrossRefPubMedPubMedCentral
4.
go back to reference Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, Chmielewski M, Cordeiro AC, Espinosa-Cuevas A, Fiaccadori E, et al. Global prevalence of protein-energy wasting in kidney disease: a Meta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018;28(6):380–92.CrossRefPubMed Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, Chmielewski M, Cordeiro AC, Espinosa-Cuevas A, Fiaccadori E, et al. Global prevalence of protein-energy wasting in kidney disease: a Meta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018;28(6):380–92.CrossRefPubMed
5.
go back to reference Wang M, Obi Y, Streja E, Rhee CM, Chen J, Hao C, Kovesdy CP, Kalantar-Zadeh K. Impact of residual kidney function on hemodialysis adequacy and patient survival. Nephrol Dial Transpl. 2018;33(10):1823–31.CrossRef Wang M, Obi Y, Streja E, Rhee CM, Chen J, Hao C, Kovesdy CP, Kalantar-Zadeh K. Impact of residual kidney function on hemodialysis adequacy and patient survival. Nephrol Dial Transpl. 2018;33(10):1823–31.CrossRef
6.
go back to reference KDOQI Clinical Practice Guideline for Hemodialysis Adequacy. 2015 update. AM J KIDNEY DIS. 2015;66(5):884–930.CrossRef KDOQI Clinical Practice Guideline for Hemodialysis Adequacy. 2015 update. AM J KIDNEY DIS. 2015;66(5):884–930.CrossRef
7.
go back to reference Chertow GM, Owen WF, Lazarus JM, Lew NL, Lowrie EG. Exploring the reverse J-shaped curve between urea reduction ratio and mortality. KIDNEY INT. 1999;56(5):1872–8.CrossRefPubMed Chertow GM, Owen WF, Lazarus JM, Lew NL, Lowrie EG. Exploring the reverse J-shaped curve between urea reduction ratio and mortality. KIDNEY INT. 1999;56(5):1872–8.CrossRefPubMed
8.
go back to reference Kaya T, Sipahi S, Cinemre H, Karacaer C, Varim C, Nalbant A, Tamer A. Relationship between the target dose for hemodialysis adequacy and nutritional assessment. ANN SAUDI MED. 2016;36(2):121–7.CrossRefPubMedPubMedCentral Kaya T, Sipahi S, Cinemre H, Karacaer C, Varim C, Nalbant A, Tamer A. Relationship between the target dose for hemodialysis adequacy and nutritional assessment. ANN SAUDI MED. 2016;36(2):121–7.CrossRefPubMedPubMedCentral
9.
go back to reference Salahudeen AK, Dykes P, May W. Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients. Nephrol Dial Transpl. 2003;18(7):1339–44.CrossRef Salahudeen AK, Dykes P, May W. Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients. Nephrol Dial Transpl. 2003;18(7):1339–44.CrossRef
10.
go back to reference Inker LA, Titan S. Measurement and estimation of GFR for Use in Clinical Practice: Core Curriculum 2021. Am J Kidney Dis. 2021;78(5):736–49.CrossRefPubMed Inker LA, Titan S. Measurement and estimation of GFR for Use in Clinical Practice: Core Curriculum 2021. Am J Kidney Dis. 2021;78(5):736–49.CrossRefPubMed
11.
go back to reference Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J AM SOC NEPHROL. 1993;4(5):1205–13.CrossRefPubMed Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J AM SOC NEPHROL. 1993;4(5):1205–13.CrossRefPubMed
12.
go back to reference Owen WJ, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329(14):1001–6.CrossRefPubMed Owen WJ, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329(14):1001–6.CrossRefPubMed
13.
go back to reference Yamada Y, Nishizawa M, Uchiyama T, Kasahara Y, Shindo M, Miyachi M, Tanaka S. Developing and validating an age-independent equation using Multi-frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and establishing a cutoff for Sarcopenia. Int J Environ Res Public Health 2017;14(7). Yamada Y, Nishizawa M, Uchiyama T, Kasahara Y, Shindo M, Miyachi M, Tanaka S. Developing and validating an age-independent equation using Multi-frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and establishing a cutoff for Sarcopenia. Int J Environ Res Public Health 2017;14(7).
14.
go back to reference Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and treatment. J AM MED DIR ASSOC. 2020;21(3):300–7.CrossRefPubMed Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and treatment. J AM MED DIR ASSOC. 2020;21(3):300–7.CrossRefPubMed
15.
go back to reference Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent JP, Nicolis I, Benazeth S, Cynober L, Aussel C. Geriatric nutritional risk index: a New Index for evaluating At-Risk Elderly Medical patients. Am J Clin Nutr. 2005;82:777–83.CrossRefPubMed Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent JP, Nicolis I, Benazeth S, Cynober L, Aussel C. Geriatric nutritional risk index: a New Index for evaluating At-Risk Elderly Medical patients. Am J Clin Nutr. 2005;82:777–83.CrossRefPubMed
16.
go back to reference Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S, Kumagai H. Simplified nutritional screening tools for patients on maintenance hemodialysis. AM J CLIN NUTR. 2008;87(1):106–13.CrossRefPubMed Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S, Kumagai H. Simplified nutritional screening tools for patients on maintenance hemodialysis. AM J CLIN NUTR. 2008;87(1):106–13.CrossRefPubMed
17.
go back to reference Canaud B, Granger VA, Molinari N, Chenine L, Leray-Moragues H, Rodriguez A, Chalabi L, Morena M, Cristol JP. Creatinine index as a surrogate of lean body mass derived from urea Kt/V, pre-dialysis serum levels and anthropometric characteristics of haemodialysis patients. PLoS ONE. 2014;9(3):e93286.ADSCrossRefPubMedPubMedCentral Canaud B, Granger VA, Molinari N, Chenine L, Leray-Moragues H, Rodriguez A, Chalabi L, Morena M, Cristol JP. Creatinine index as a surrogate of lean body mass derived from urea Kt/V, pre-dialysis serum levels and anthropometric characteristics of haemodialysis patients. PLoS ONE. 2014;9(3):e93286.ADSCrossRefPubMedPubMedCentral
18.
19.
go back to reference Churchill BM, Patri P. The nitty-gritties of Kt/Vurea calculations in Hemodialysis and Peritoneal Dialysis. Indian J Nephrol. 2021;31(2):97–110. Churchill BM, Patri P. The nitty-gritties of Kt/Vurea calculations in Hemodialysis and Peritoneal Dialysis. Indian J Nephrol. 2021;31(2):97–110.
20.
go back to reference Sun Y, Wang Y, Yu W, Zhuo Y, Yuan Q, Wu X. Association of dose and frequency on the survival of patients on maintenance of hemodialysis in China: A Kaplan–Meier and cox proportional hazard model analysis. Med Sci Monit. 2018;24:5329–37.CrossRefPubMedPubMedCentral Sun Y, Wang Y, Yu W, Zhuo Y, Yuan Q, Wu X. Association of dose and frequency on the survival of patients on maintenance of hemodialysis in China: A Kaplan–Meier and cox proportional hazard model analysis. Med Sci Monit. 2018;24:5329–37.CrossRefPubMedPubMedCentral
21.
go back to reference Liu SX, Wang ZH, Zhang S, Xiao J, You LL, Zhang Y, Dong C, et al. The association between dose of hemodialysis and patients mortality in a prospective cohort study. Sci Rep. 2022;12(1):13708.ADSCrossRefPubMedPubMedCentral Liu SX, Wang ZH, Zhang S, Xiao J, You LL, Zhang Y, Dong C, et al. The association between dose of hemodialysis and patients mortality in a prospective cohort study. Sci Rep. 2022;12(1):13708.ADSCrossRefPubMedPubMedCentral
22.
go back to reference Lu J, Zhu M, Liu S, Zhu M, Pang H, Lin X, et al. The relationship between survival rate and intradialytic blood pressure changes in maintenance hemodialysis patients. Ren Fail. 2017;39(1):417–22.CrossRefPubMedPubMedCentral Lu J, Zhu M, Liu S, Zhu M, Pang H, Lin X, et al. The relationship between survival rate and intradialytic blood pressure changes in maintenance hemodialysis patients. Ren Fail. 2017;39(1):417–22.CrossRefPubMedPubMedCentral
23.
go back to reference AlSahow A, Muenz D, Al-Ghonaim MA, Al SI, Hassan M, Al AA, et al. Kt/V: achievement, predictors and relationship to mortality in hemodialysis patients in the Gulf Cooperation Council countries: results from DOPPS (2012–18) clin. Kidney J. 2021;14(3):820–30. AlSahow A, Muenz D, Al-Ghonaim MA, Al SI, Hassan M, Al AA, et al. Kt/V: achievement, predictors and relationship to mortality in hemodialysis patients in the Gulf Cooperation Council countries: results from DOPPS (2012–18) clin. Kidney J. 2021;14(3):820–30.
24.
go back to reference Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van Wyck D, et al. Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis. 2010;55(1):100–12.CrossRefPubMed Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van Wyck D, et al. Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis. 2010;55(1):100–12.CrossRefPubMed
25.
go back to reference Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010–9.CrossRefPubMed Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010–9.CrossRefPubMed
26.
go back to reference Wang M, Liu L, Shen X, Li Y, He Q. Assessing lean tissue by bioelectrical impedance analysis pre hemodialysis underestimates the prevalence of Sarcopenia in maintenance hemodialysis patients. EUR J CLIN NUTR. 2021;75(9):1407–13.CrossRefPubMed Wang M, Liu L, Shen X, Li Y, He Q. Assessing lean tissue by bioelectrical impedance analysis pre hemodialysis underestimates the prevalence of Sarcopenia in maintenance hemodialysis patients. EUR J CLIN NUTR. 2021;75(9):1407–13.CrossRefPubMed
27.
go back to reference Perez-Garcia R, Jaldo M, Alcazar R, de Sequera P, Albalate M, Puerta M, Ortega M, Ruiz MC, Corchete E. Unlike kt, high Kt/V is associated with greater mortality: the importance of low V. Nefrologia (Engl Ed). 2019;39(1):58–66.CrossRefPubMed Perez-Garcia R, Jaldo M, Alcazar R, de Sequera P, Albalate M, Puerta M, Ortega M, Ruiz MC, Corchete E. Unlike kt, high Kt/V is associated with greater mortality: the importance of low V. Nefrologia (Engl Ed). 2019;39(1):58–66.CrossRefPubMed
28.
go back to reference Beguin L, Krummel T, Longlune N, Galland R, Couchoud C, Hannedouche T. Dialysis dose and mortality in haemodialysis: is higher better? Nephrol Dial Transpl. 2021;36(12):2300–7.CrossRef Beguin L, Krummel T, Longlune N, Galland R, Couchoud C, Hannedouche T. Dialysis dose and mortality in haemodialysis: is higher better? Nephrol Dial Transpl. 2021;36(12):2300–7.CrossRef
29.
go back to reference Piccoli GB, Lippi F, Fois A, Gendrot L, Nielsen L, Vigreux J, Chatrenet A, D’Alessandro C, Cabiddu G, Cupisti A. Intradialytic Nutrition and Hemodialysis prescriptions: a personalized Stepwise Approach. Nutrients. 2020;12(3):785.CrossRefPubMedPubMedCentral Piccoli GB, Lippi F, Fois A, Gendrot L, Nielsen L, Vigreux J, Chatrenet A, D’Alessandro C, Cabiddu G, Cupisti A. Intradialytic Nutrition and Hemodialysis prescriptions: a personalized Stepwise Approach. Nutrients. 2020;12(3):785.CrossRefPubMedPubMedCentral
30.
go back to reference Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, Kusek JW, Leung J, Burrowes JD, McLeroy SL, et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study. KIDNEY INT. 2004;65(6):2321–34.CrossRefPubMed Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, Kusek JW, Leung J, Burrowes JD, McLeroy SL, et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study. KIDNEY INT. 2004;65(6):2321–34.CrossRefPubMed
31.
go back to reference Debowska M, Paniagua R, Ventura MD, Avila-Diaz M, Prado-Uribe C, Mora C, Garcia-Lopez E, Qureshi AR, Lindholm B, Waniewski J. Dialysis adequacy indices and body composition in male and female patients on peritoneal dialysis. Perit Dial Int. 2014;34(4):417–25.CrossRefPubMedPubMedCentral Debowska M, Paniagua R, Ventura MD, Avila-Diaz M, Prado-Uribe C, Mora C, Garcia-Lopez E, Qureshi AR, Lindholm B, Waniewski J. Dialysis adequacy indices and body composition in male and female patients on peritoneal dialysis. Perit Dial Int. 2014;34(4):417–25.CrossRefPubMedPubMedCentral
32.
go back to reference Xiong J, Wang M, Zhang Y, Nie L, He T, Wang Y, Huang Y, Feng B, Zhang J, Zhao J. Association of Geriatric Nutritional Risk Index with Mortality in Hemodialysis patients: a Meta-analysis of Cohort studies. Kidney Blood Press Res. 2018;43(6):1878–89.CrossRefPubMed Xiong J, Wang M, Zhang Y, Nie L, He T, Wang Y, Huang Y, Feng B, Zhang J, Zhao J. Association of Geriatric Nutritional Risk Index with Mortality in Hemodialysis patients: a Meta-analysis of Cohort studies. Kidney Blood Press Res. 2018;43(6):1878–89.CrossRefPubMed
33.
go back to reference Guo Y, Zhang M, Ye T, Wang Z, Yao Y. Application of Bioelectrical Impedance Analysis in Nutritional Management of patients with chronic kidney disease. Nutrients. 2023;15(18):3941.CrossRefPubMedPubMedCentral Guo Y, Zhang M, Ye T, Wang Z, Yao Y. Application of Bioelectrical Impedance Analysis in Nutritional Management of patients with chronic kidney disease. Nutrients. 2023;15(18):3941.CrossRefPubMedPubMedCentral
34.
go back to reference Zhou DC, Yang XH, Zhan XL, Gu YH, Guo LL, Jin HM. Association of lean body mass with nutritional parameters and mortality in hemodialysis patients: a long-term follow-up clinical study. Int J Artif Organs. 2018;41(6):297–305.CrossRefPubMed Zhou DC, Yang XH, Zhan XL, Gu YH, Guo LL, Jin HM. Association of lean body mass with nutritional parameters and mortality in hemodialysis patients: a long-term follow-up clinical study. Int J Artif Organs. 2018;41(6):297–305.CrossRefPubMed
35.
go back to reference Oliveira T, Garagarza C, Valente A, Caetano C. Low body cell mass index in hemodialysis patients: Association with clinical parameters and survival. Hemodial Int. 2020;24(2):228–36.CrossRefPubMed Oliveira T, Garagarza C, Valente A, Caetano C. Low body cell mass index in hemodialysis patients: Association with clinical parameters and survival. Hemodial Int. 2020;24(2):228–36.CrossRefPubMed
36.
go back to reference Yajima T, Yajima K, Takahashi H, Yasuda K. Combined Predictive Value of Extracellular Fluid/Intracellular Fluid Ratio and the Geriatric Nutritional Risk Index for Mortality in Patients Undergoing Hemodialysis. NUTRIENTS 2019;11(11). Yajima T, Yajima K, Takahashi H, Yasuda K. Combined Predictive Value of Extracellular Fluid/Intracellular Fluid Ratio and the Geriatric Nutritional Risk Index for Mortality in Patients Undergoing Hemodialysis. NUTRIENTS 2019;11(11).
37.
go back to reference Fujioka H, Koike T, Imamura T, Tomoda F, Kakeshita K, Yamazaki H, Kinugawa K. Impact of Geriatric Nutritional Risk Index and Modified Creatinine Index Combination on Mortality in Hemodialysis Patients. NUTRIENTS 2022;14(4). Fujioka H, Koike T, Imamura T, Tomoda F, Kakeshita K, Yamazaki H, Kinugawa K. Impact of Geriatric Nutritional Risk Index and Modified Creatinine Index Combination on Mortality in Hemodialysis Patients. NUTRIENTS 2022;14(4).
38.
go back to reference Rippe B, Oberg CM. Albumin turnover in peritoneal and Hemodialysis. Semin Dial. 2016;29(6):458–62.CrossRefPubMed Rippe B, Oberg CM. Albumin turnover in peritoneal and Hemodialysis. Semin Dial. 2016;29(6):458–62.CrossRefPubMed
39.
go back to reference Sabatino A, Regolisti G, Karupaiah T, Sahathevan S, Sadu Singh BK, Khor BH, Salhab N, Karavetian M, Cupisti A, Fiaccadori E. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis. Clin Nutr. 2017;36(3):663–71.CrossRefPubMed Sabatino A, Regolisti G, Karupaiah T, Sahathevan S, Sadu Singh BK, Khor BH, Salhab N, Karavetian M, Cupisti A, Fiaccadori E. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis. Clin Nutr. 2017;36(3):663–71.CrossRefPubMed
40.
go back to reference Movilli E. Adequacy, nutrition, and biocompatibility: their relevance on clinical outcome in haemodialysis patients. Blood Purif. 1999;17(2–3):159–65.CrossRefPubMed Movilli E. Adequacy, nutrition, and biocompatibility: their relevance on clinical outcome in haemodialysis patients. Blood Purif. 1999;17(2–3):159–65.CrossRefPubMed
Metadata
Title
Single-pool model urea clearance index is associated with sarcopenia and nutritional status in patients undergoing maintenance hemodialysis: a cross-sectional study
Authors
Yan Li
Tingting Xing
Rong Xu
Yan Liu
Xiaoshi Zhong
Yun Liu
Rongshao Tan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03510-4

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.